Skip to main content
OpenTrials

Clinical trial condition

Hyperlipidemias

Explore clinical trials studying Hyperlipidemias. Study availability and eligibility vary by location and protocol.

686 public trials 58 recruiting studies
Refine in advanced search Browse all conditions

Hyperlipidemias trial results

Completed

A Study To Evaluate The Safety And Efficacy Of Atorvastatin In Patients With Diabetes And High Cholesterol

NCT00645424

Conditions
Dyslipidemias, Hyperlipidemias, Lipid Metabolism Disorders, +2 more
Locations
  • Pfizer Investigational Site Kaohsiung City, Taiwan
  • Pfizer Investigational Site Kaohsiung Hsien, Taiwan
  • Pfizer Investigational Site Taichung, Taiwan
  • Pfizer Investigational Site Taipei, Taiwan
View Trial Details
Completed

A Swiss Study With Atorvastatin in Hyperlipidemic Patients Measuring LDL-Cholesterol

NCT00136942

Conditions
Dyslipidemias, Hyperlipidemia, Hyperlipidemias, +3 more
Locations
  • Pfizer Investigational Site Binningen, Basel-Landschaft, Switzerland
  • Pfizer Investigational Site Liestal, Basel-Landschaft, Switzerland
  • Pfizer Investigational Site Basel, Canton of Basel-City, Switzerland
  • Pfizer Investigational Site Langenthal, Canton of Bern, Switzerland
View all 20 locations
View Trial Details
Completed

Amlodipine/Atorvastatin Combination to Reduce the Health Risk of High Blood Pressure and High Cholesterol Levels

NCT00143234

Conditions
Cardiovascular Diseases, Dyslipidemias, Hyperlipidemia, +6 more
Locations
  • Pfizer Investigational Site Buenos Aires, Argentina
  • Pfizer Investigational Site Buenos Aires, Argentina
  • Pfizer Investigational Site Buenos Aires, Argentina
  • Pfizer Investigational Site Buenos Aires, Argentina
View all 118 locations
View Trial Details
Completed

Open Label Study To Assess The Effectiveness Of Amlodipine-Atorvastatin Combination In Hypertension And Dyslipidemia.

NCT00174304

Conditions
Cardiovascular Diseases, Dyslipidemias, Hyperlipidemia, +6 more
Locations
  • Pfizer Investigational Site Salzburg, Austria
  • Pfizer Investigational Site Sankt Pölten, Austria
  • Pfizer Investigational Site Vienna, Austria
  • Pfizer Investigational Site Wels, Austria
View all 102 locations
View Trial Details
Completed

Comparing Amlodipine/Atorvastatin Co-Administration To Amlodipine Alone In Patients With Hypertension And Dyslipidemia

NCT00174330

Conditions
Cardiovascular Diseases, Dyslipidemias, Hyperlipidemia, +6 more
Locations
  • Pfizer Investigational Site Beijing, Beijing Municipality, China
  • Pfizer Investigational Site Guangzhou, Guangdong, China
  • Pfizer Investigational Site Guangzhou, Guangdong, China
  • Pfizer Investigational Site Guangzhou, Guangdong, China
View all 15 locations
View Trial Details

Related conditions